Medical Science Liaison, Neurodegeneration

• Develops trusted relationships with appropriate academic and community Thought Leaders (TLs) in neurology through high-quality peer-to-peer scientific dialogue in both proactive and reactive settings.

• The MSL will use various channels for interactions (1:1, group presentations, virtual, etc.)

• Medical engagement:
Effectively collaborates and engages in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch

• Proactively engages in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities.

• Engages with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate.

• Provides training for external speakers as needed.

• Strategically engages payers in the pre- and peri-launch phases (with fHEOR and Account Executives).

• Provides medical support to address unsolicited HCP questions in real-time, both in face-to-face interactions and through the Medical on Call virtual capability.

• Develops credible connections with key Thought Leaders (TLs) in neurology through high-quality peer-to-peer scientific dialogue.

• Appropriately document and achieve annual goals

• Leverages digital capabilities to enhance medical engagement

• Clinical Trial engagement:
Provides recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO.

• Liaises with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials.

• Leads major evidence read-outs with clinical trial investigators e.g., Ph 3 top-line data.

• Support Interventional and Non-Interventional Research (NIR) studies (e.g., identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products, as agreed with home office medical and Global Development Operations (GDO) and as defined by the study scope document.

• Provide recommendations and insights to clinical development team on study and site feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO

• Support HCPs in the ISR submission and execution process and study follow-up as agreed upon with home office medical and GDO

• Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events.

• If applicable, support CRO sponsored studies as agreed with home office medical and GDO and as defined by the study scope document.

Requirements

• MD, PharmD, PhD, APP, PA, NP with experience in a specific Disease Area or with a broad medical background or relevant pharmaceutical experience
• Working in a scientific and/or clinical research environment.
• Field medical expertise is preferred.
• Deep understanding of TL environment and needs.
• Strong neurology experience required:
  Scientific or clinical disease area knowledge, patient treatment trends, clinical landscape
• Pharmaceutical industry including compliance and regulatory guidelines
• Understanding of scientific publications:
  Clinical trial design and process
• Understanding of national and regional healthcare and access environment.
• Key competencies desired:
  Scientific Agility
• Ability to engage in a dialogue about data in a compelling, fair and balanced way and explain in a manner that resonates with TLs/HCPs
• Expert knowledge of clinical practice and evolving healthcare delivery models.
• Ability to understand and critically appraise scientific publications.
• Knowledge of clinical trial design and methodology, including Good Clinical Practices and ethical, governmental, and regulatory requirements.
• Understands treatment paradigms, competitive…